Usamrdc cccrp r & d contract (proposal BA230047)titled "mild traumatic brain injury biomarker study, a prospective cohort biomarker study of military and civilian participants with mtbi: mtbi-predict"
Active Definitive Contract Awarded Last action
- Contract number
- HT942523C0066
- Awardee
-
University Of Birmingham UEI L4NJBZ31UKK3
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $6,040,000
Award facts
- Opportunity
-
- DOD USAMRDC FY23-FY27 BROAD AGENCY ANNOUNCEMENT for Extramural Medical Research Department of Defense Dept. of the Army -- USAMRAA Special Notice · HT942523SBAA1 · Posted Sep 29, 2022
- Contract value 39% obligated
-
- $10,922,527.44 Current, with exercised options
- $15,491,795.28 Potential, with all options
- Completion date 44% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Basic Research
- Pricing
- Cost No Fee
- Place of performance
- Great Britain, United Kingdom
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $0 | |
| Change Order | $2,040,000 | |
| Funding Only Action | $2,000,000 | |
| Original award | $2,000,000 |
About this award
The Defense Health Agency awarded a $15.5 million definitive contract to University of Birmingham for a prospective cohort biomarker study on mild traumatic brain injury (MTBI-PREDICT) on September 25, 2023, under cost-no-fee pricing with no set-aside.
The contract funds a research effort titled "Mild Traumatic Brain Injury Biomarker Study: A Prospective Cohort Biomarker Study of Military and Civilian Participants with MTBI" (Proposal BA230047), originating from the U.S. Army Medical Research and Development Command Competitive Clinical Core Research Program. The study enrolls both military personnel and civilian participants to advance biomarker understanding in traumatic brain injury, supporting USAMRDC's mission of generating medical solutions for service members and the public.
Place of performance is Great Britain, United Kingdom. The ultimate completion date is September 29, 2030.
Quick answers
Who was awarded contract HT942523C0066?
HT942523C0066 was awarded to University Of Birmingham by Defense Health Agency (Department of Defense) on September 25, 2023.
How much is contract HT942523C0066 worth?
The government has obligated $6,040,000 on HT942523C0066. Its current value, with exercised options, is $10,922,527. Its potential value, with all options, is $15,491,795.
Was contract HT942523C0066 competed?
The extent of competition for HT942523C0066 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award